JW

Justin Ward

Recce Pharmaceuticals Ltd | Executive Director
Dr Ward has specialisation in pharmaceutical quality management and product development. Before Recce Pharmaceuticals, he held a technical speciality and special project leadership role with Pfizer Pharmaceuticals, involving providing data for the regulatory submissions to the FDA and TGA. After Pfizer, he was the Laboratory Manager for Solbec, involving, again as presently, drug specifications and pharmaceutical trials for the ASX-Listed company. Most recently, he was Quality Manager at Phebra and responsible for product quality and release of all drugs of the company with the TGA.

Company and Role

Company
Title
Tenure
Since
RCE
Recce Pharmaceuticals Ltd
  • Executive Director
4yrs, 10mthJul 2019

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RCE
Recce Pharmaceuticals Ltd
07/12/23301,444N/A600,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RCE
Recce Pharmaceuticals Ltd
07/12/23
Issued
136,364$0.440$60,000Rights issue
RCE
Recce Pharmaceuticals Ltd
29/09/23
Issued
6,114$0.440$2,690Rights issue
RCE
Recce Pharmaceuticals Ltd
22/02/21
Issued
600,000$1.030$618,000Issue of options
RCE
Recce Pharmaceuticals Ltd
19/12/19
Issued
43,478$0.310$13,478Director remuneration